News

41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) was held between September 24th–26th in Barcelona, Spain. IMMUTOL was represented by team members from the Institut de Recerca Germans Trias i Pujol (IGTP): Alex Agúndez Moreno and Cristina Ramo Tello, along with our collaborator, the European Multiple Sclerosis Platform (EMSP).

The paper recently published in the British Journal of Clinical Pharmacology is entitled: Early-stage health technology assessment of a curative gene therapy for multiple sclerosis. Link to the article: http://doi.org/10.1002/bcp.70204 As indicated in the paper abstract, the authors conclude that ‘IMMUTOL gene therapy shows promising cost-effectiveness at a value-based price up to approximately €500 000, contingent on achieving curative clinical efficacy.…

EMSP is the umbrella organization for national Multiple Sclerosis (MS) organizations in Europe and has been the leading voice for people with MS for over 30 years. EMSP works with members, partners, and individuals with MS across the EU to influence policies that ensure equitable treatment, care, and resources for those affected by MS, promoting their inclusion in…

The 2nd Annual Meeting of IMMUTOL consortium took place in Budapest between the 27th and 28th of May, 2025 hosted by SRI and organised by INN-Acta. The first day of the event was focused on progress updates given by several young scientist focused on activities in WP2 (Optimization of monocyte collection to improve advanced VitD3DC generation), WP3 (To…

SAVE THE DATE!  IMMUTOL’s 2nd Annual Meeting will take place on May 27-28, 2025, at the Lion’s Garden Hotel in Budapest, Hungary.

Luis Soria Jiménez, postdoctoral researcher and Ana María Barriocanal, MD, PhD joined the IMMUTOL projects from Institute de Investigacion en Ciencias de la Salut Germans Trias I Pujol. Welcome!

Cristina Rosell, PhD recently joined the Immutol team from ASPHALION! Welcome!

PhD student Alex Agúndez Moreno, from IGTP team, presented his work at the XVIII Congress of the Catalan Society of Immunology, held between  21st  and 22nd November 2024 in Barcelona. The poster presentation was entitled: ‘VitD3tolDC reduce the transmigration of allogeneic CD4 T cells in an in vitro transwell assay’.

IGTP team have an interview to the Badalona Comunicació newspaper. The article is entitled: ‘Fàrmacs combinats amb cèl·lules ‘reeducades’ in vitro, via de recerca per frenar l’avenç de l’esclerosi múltiple’ Link to the article: https://www.bdncom.cat/notice/farmacs-combinats-amb-cellules-reeducades-in-vitro-via-de-recerca-per-frenar-lavenc-de-lesclerosi-multiple?v=2024-11-08T14:17

Dr. Silvia Gregori, gave a talk at the Immunology of Diabetes Congress, which is a reference conference on pathogenesis, prediction, prevention and cure of Type 1 Diabetes. The conference was  organized by the Immunology of Diabetes Society (IDS) in Bruges between 4th-8th November. Her talk was entitled ‘Antigen-specific engineered dendritic cells for cell-based approaches to restore…